首页|川芎嗪激活Nrf2/HO-1/CXCR4通路调控神经干细胞迁移干预缺血再灌注大鼠的作用机制

川芎嗪激活Nrf2/HO-1/CXCR4通路调控神经干细胞迁移干预缺血再灌注大鼠的作用机制

Mechanism of tetramethylpyrazine intervention with ischemia-reperfusion rats based on Nrf2/HO-1/CXCR4 pathway through regulating neural stem cell migration

扫码查看
以核因子E2 相关因子2(nuclear factor erythroid 2-related factor 2,Nrf2)/血红素加氧酶1(heme oxygenase 1,HO-1)/趋化因子C-X-C-基元受体 4(C-X-C motif chemokine receptor 4,CXCR4)通路为切入点,探讨川芎嗪(tetramethylpyrazine,TMP)干预大脑中动脉阻塞(middle cerebral artery occlusion,MCAO)模型大鼠脑内神经干细胞(neural stem cells,NSCs)迁移的作用机制.SD大鼠分为假手术组、模型组、TMP 20 mg·kg-1组和TMP 40 mg·kg-1组;通过神经功能缺失评分评价神经功能损伤;免疫荧光法检测脑组织 5-溴脱氧尿苷(5-bromodeoxyuridine,BrdU)/双皮质素(doublecortin,DCX)双标细胞;观察TMP 对C17.2 细胞迁移的影响;蛋白免疫印迹法检测脑组织和C17.2 细胞中Nrf2、HO-1、p62、醌氧化还原酶 1[NAD(P)H quinone oxidoreduc-tase 1,NQO1]、基质细胞衍生因子 1(stromal cell-derived factor 1,SDF-1)、CXCR4 蛋白表达.结果显示,大鼠脑缺血 7、21 d后,神经功能损伤评分及BrdU+/DCX+细胞显著升高,脑组织中Nrf2 及CXCR4 表达均显著升高;与模型组相比,TMP 40 mg·kg-1可显著降低神经功能评分,进一步升高BrdU+/DCX+细胞数量及Nrf2、CXCR4 及SDF-1 表达;此外TMP 可以显著促进C17.2细胞迁移,且时间以及剂量依赖性提高p62、Nrf2、HO-1、NQO1 表达,TMP 50 μg·mL-1给药 12 h表达量最高(P<0.01).综上,TMP可通过活化Nrf2/HO-1/CXCR4 通路,促进NSCs迁移从而发挥抗缺血再灌注损伤作用.该研究为TMP在缺血性脑卒中疾病中的应用提供了实验支持.
This study aims to decipher the mechanism of tetramethylpyrazine(TMP)in regulating the migration of neural stem cells(NSCs)in the rat model of middle cerebral artery occlusion(MCAO)via the nuclear factor erythroid 2-related factor 2(Nrf2)/heme oxygenase 1(HO-1)/C-X-C motif chemokine receptor 4(CXCR4)pathway.SD rats were randomized into sham,MCAO(model),and tetramethylpyrazine(TMP,20 mg·kg-1 and 40 mg·kg-1)groups.The neurological impairment was assessed by the modified neu-rological severity score(mNSS).The immunofluorescence assay was employed to detect the cells stained with both 5-bromodeoxyuri-dine(BrdU)and doublecortin(DCX)in the brain tissue.The effect of TMP on the migration of C17.2 cells was observed.Western blot was employed to determine the protein levels of Nrf2,HO-1,p62,NAD(P)H quinone oxidoreductase 1(NQO1),stromal cell-derived factor 1(SDF-1),and CXCR4 in the brain tissue and C17.2 cells.The results showed that after 7 days and 21 days of mode-ling,the mNSS and BrdU+/DCX+cells were increased,and the expression of Nrf2 and CXCR4 in the brain tissue was up-regulated.Compared with the model group,TMP(40 mg·kg-1)reduced the mNSS,increased the number of BrdU+/DCX+cells,and up-regula-ted the expression of Nrf2,CXCR4,and SDF-1.In addition,TMP promoted the migration of C17.2 cells and up-regulated the expres-sion of p62,Nrf2,HO-1,and NQO1 in a time-and dose-dependent manner.The expression was the highest at the time point of 12 h in the TMP(50 μg·mL-1)group(P<0.01).In conclusion,TMP activates the Nrf2/HO-1/CXCR4 pathway to promote the migration of NSCs to the ischemic area,thus exerting the therapeutic effect on the ischemia-reperfusion injury.This study provides experimental support for the application of TMP in ischemic stroke.

middle cerebral artery occlusiontetramethylpyrazinemigration of neural stem cellsNrf2/HO-1/CXCR4 pathway

李卓航、王栋、王艳秋、戚明珠、黄荷兰、林娜、苏晓慧、孔祥英

展开 >

中国中医科学院 中药研究所,北京 100700

大脑中动脉阻塞 川芎嗪 神经干细胞迁移 Nrf2/HO-1/CXCR4通路

北京市自然科学基金面上项目国家自然科学基金面上项目国家自然科学基金面上项目中国中医科学院科技创新工程重大攻关项目

72222918207404881673630CI2021A04610

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(9)
  • 33